tiprankstipranks
Trending News
More News >
Anbio Biotechnology Class A (NNNN)
:NNNN
US Market

Anbio Biotechnology Class A (NNNN) Financial Statements

Compare
47 Followers

Anbio Biotechnology Class A Financial Overview

Anbio Biotechnology Class A's market cap is currently $4.16B. The company's EPS TTM is $0.06; its P/E ratio is 476.90; Anbio Biotechnology Class A is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Currency in USD

Anbio Biotechnology Class A Earnings and Revenue History

Anbio Biotechnology Class A Debt to Assets

Anbio Biotechnology Class A Cash Flow

Anbio Biotechnology Class A Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.